Tumour front inflammation and necrosis are independent prognostic predictors in high-grade urothelial carcinoma of the bladder

J Clin Pathol. 2018 Feb;71(2):154-160. doi: 10.1136/jclinpath-2017-204562. Epub 2017 Aug 2.

Abstract

Aims: Inflammation and necrosis have been associated with prognosis in multiple epithelial malignancies. Our objective was to evaluate inflammation and necrosis in a cohort of patients with high-grade urothelial carcinomas of the bladder to determine their association with pathological parameters and their prognostic effect on relapse-free and disease-specific survival.

Methods: A retrospective cohort that underwent radical cystectomy for urothelial carcinomas (n=235) was evaluated for invasive front and central inflammation using the Klintrup-Makinen assessment method. Necrosis was scored using a four-point scale. The relationship of inflammation and necrosis with stage, nodal status, carcinoma in situ, tumour size, margin status and vascular space invasion and the impact on relapse-free and disease-specific survival were calculated using appropriate statistical tests.

Results: On multivariate analysis, invasive front inflammation (p=0.003) and necrosis (p=0.000) were independent predictors of relapse-free survival. Both invasive front inflammation (p=0.009) and necrosis (p=0.002) again were independent predictors of disease-specific survival. For pathological features, low invasive front inflammation was associated with lymphovascular space invasion (p=0.008), a positive soft tissue margin (p=0.028) and carcinoma in situ (p=0.042). Necrosis was statistically associated with tumours >3 cm in size (p=0.013) and carcinoma in situ (p<0.001).

Conclusions: Necrosis and invasive front inflammation are additional histological variables with independent prognostic relevance in high-grade urothelial carcinoma of the bladder.

Keywords: bladder; inflammation; necrosis; prognosis; urothelial.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Carcinoma, Transitional Cell / diagnosis*
  • Carcinoma, Transitional Cell / mortality
  • Carcinoma, Transitional Cell / pathology*
  • Carcinoma, Transitional Cell / surgery
  • Cystectomy
  • Female
  • Follow-Up Studies
  • Humans
  • Inflammation / pathology*
  • Male
  • Middle Aged
  • Necrosis / pathology*
  • Neoplasm Grading
  • Observer Variation
  • Prognosis
  • Retrospective Studies
  • Survival Analysis
  • Urinary Bladder / pathology*
  • Urinary Bladder / surgery
  • Urinary Bladder Neoplasms / diagnosis*
  • Urinary Bladder Neoplasms / mortality
  • Urinary Bladder Neoplasms / pathology*
  • Urinary Bladder Neoplasms / surgery